Notes / Company

Unichem Laboratories Ltd.

UNICHEMLAB BSE 506690 ISIN INE351A01035 Pharmaceuticals

Fundamentals

Market cap: ₹3,049 cr
P/E: 12.06×
ROE: 5.61%
Debt / equity: 0.18
52-week range: 278.20 — 657.95

Research on Tijori Finance

Company snapshot

Unichem Laboratories Ltd.

Pharmaceuticals

₹2,621 cr

P/E 10.36×

Latest quarter · Mar 2026

Sales₹575 cr

Net profit₹11 cr

Op. margin+8.3%

EPS₹1.55

Strength & growth

Debt / equity0.18×

Current ratio2.05×

Sales CAGR+6.0%

EPS CAGR+14.1%

The timeline — 1 note on Unichem Laboratories Ltd.

May 2026

22 May 26 · 4:43 PM IST Brief

Brief · Earnings · Small cap

Unichem Laboratories annual profit fell on labour code charges

Consolidated profits slid to ₹90.5 cr as exceptional costs weighed on earnings, even as a land sale kept standalone profit steady.

Verify on exchange BSE filings for UNICHEMLAB NSE filings for UNICHEMLAB Tijori Finance company page